FDA Warning Letter — Apozeal Pharmaceuticals Inc.

Case 584701 — FEI 3004536846

The FDA took a Warning Letter action against Apozeal Pharmaceuticals Inc. on October 28, 2019 (Levittown, PA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Apozeal Pharmaceuticals Inc.
Date
October 28, 2019
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
Levittown, PA (United States)